Modeling the Impact of Smoking-Cessation Treatment Policies on Quit Rates

American Journal of Preventive Medicine

Volumn 38, Issue 3 SUPPL. 1, 2010, Pages

  Levy, David T ^a   Graham, Amanda L ^c   Mabry, Patricia L ^b   Abrams, David B ^c   Orleans, C Tracy ^d  

^a UNIVERSITY OF BALTIMORE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c American Legacy Foundation   (United States)

^d ROBERT WOOD JOHNSON FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; NOSE SPRAY; VARENICLINE;

ARTICLE; FUNDING; HEALTH CARE; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROMOTION; INTERNET; LOZENGE; REIMBURSEMENT; SMOKING CESSATION; TELECONSULTATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADULT; DELIVERY OF HEALTH CARE; DIRECTIVE COUNSELING; EVIDENCE-BASED PRACTICE; HEALTH PROMOTION; HUMANS; INTERNET; MODELS, STATISTICAL; MOTIVATION; POLICY MAKING; PROGRAM EVALUATION; SMOKING; SMOKING CESSATION; TELEPHONE; UNITED STATES;

EID: 76749097107     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.11.016     Document Type: Article

References (31)

1. Abrams D. Comprehensive smoking cessation policy for all smokers: systems integration to save lives and money. In: Bonnie R.J., Stratton K., and Wallace R.B. (Eds). Ending the tobacco problem: a blueprint for the nation (2007), The National Academies Press, Washington
2. Orleans C.T. Increasing the demand for and use of effective smoking-cessation treatments reaping the full health benefits of tobacco-control science and policy gains-in our lifetime. Am J Prev Med 33 6S (2007) S340-S348
3. Gollust S., Schroeder S., and Warner K. Helping smokers quit: understanding the barriers to utilization of smoking cessation services. The Millbank Quarterly 86 4 (2008) 601-627
4. Fiore M., Jaén C., Baker T., et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline (2008), USDHHS, Public Health Service, Rockville MD
5. Fiore M., Bailey W., Cohen S., et al. Treating tobacco use and dependence. Clinical practice guideline (2000), USDHHS, Public Health Service, Rockville MD
6. Friend K., and Levy D. Smoking cessation interventions and policies to promote their use: a critical review. Nicotine Tob Res 3 November (2001) 299-310
7. Levy D.T., and Friend K. A simulation model of policies directed at treating tobacco use and dependence. Med Decis Making 22 1 (2002) 6-17
8. Levy D.T., and Friend K. Examining the effects of tobacco treatment policies on smoking rates and smoking-related deaths using the SimSmoke computer simulation model. Tob Control 11 1 (2002) 47-54
9. Abrams D.B., Graham A.L., Levy D.T., Mabry P.L., and Orleans C.T. Boosting population quits through evidence-based cessation treatment and policy. Am J Prev Med 38 3S (2010) S351-S363
10. U.S. Census Bureau. Current population survey, February, June, and November 2003: tobacco use supplement conducted by the U.S. Census Bureau for the Bureau of Labor Statistics (2006), U.S. Census Bureau, Washington. http://riskfactor.cancer.gov/studies/tus-cps/surveys/cps_fjn03_tech_doc.pdf
11. Cahill K., Stead L.F., and Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 1 (2007) CD006103
12. Hughes J.R., Shiffman S., Callas P., and Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 12 1 (2003) 21-27
13. Hughes J.R., Stead L.F., and Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 1 (2007) CD000031
14. Hughes J.R., Stead L.F., and Lancaster T. Nortriptyline for smoking cessation: a review. Nicotine Tob Res 7 4 (2005) 491-499
15. Lancaster T., and Stead L.F. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2 (2005) CD001292
16. Lancaster T., and Stead L.F. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 3 (2005) CD001118
17. Stead L.F., and Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2 (2005) CD001007
18. Stead L.F., Perera R., Bullen C., Mant D., and Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 1 (2008) CD000146
19. Stead L.F., Perera R., and Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob Control 16 1S (2007) i3-i8
20. Cohen S., Lichtenstein E., Prochaska J.O., et al. Debunking myths about self-quitting: evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol 44 11 (1989) 1355-1365
21. Hughes J.R., Gulliver S.B., Fenwick J.W., et al. Smoking cessation among self-quitters. Health Psychology 11 (1992) 331-334
22. Hughes J.R., Peters E.N., and Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict Behav 33 12 (2008) 1516-1520
23. Burns D., Anderson C., Johnson M., et al. Cessation and cessation measures among daily adult smokers: national- and state-specific data. Institute NC, ed. Population-based smoking cessation: a conference on what works to influence smoking in the general population. Smoking and Tobacco Control Monograph No. 12 (2000), National Cancer Institute, NIH, Bethesda MD
24. North American Quitline Consortium. North American quitlines: a profile of reach and services across the U.S. and Canada-2006 (2008), North American Quitline Consortium, Phoenix AZ. http://www.naquitline.org
25. Kaper J., Wagena E.J., Severens J.L., and Van Schayck C.P. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev 1 (2005) CD004305
26. Schauffler H.H., McMenamin S., Olson K., Boyce-Smoth G., Rideout J.A., and Kamil J. Variations in treatment benefits influence smoking cessation: results of a randomized controlled trial. Tob Control 10 (2001) 175-180
27. CDC. Prevalence of current smoking among adults aged 18 years and over: US. 2008. Early release of selected estimates based on data from the 2008 National Health Interview Survey (2009), CDC, Atlanta GA. www.cdc.gov/nchs/nhis/released200906_08.pdf
28. Pierce J.P., and Gilpin E.A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 288 10 (2002) 1260-1264
29. Thorndike A.N., Biener L., and Rigotti N.A. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 92 3 (2002) 437-442
30. Levy D.T., Mabry P.L., Graham A.L., Orleans C.T., and Abrams D.B. Reaching Healthy People 2010 by 2013: a SimSmoke simulation. Am J Prev Med 38 3S (2010) S373-S381
31. Bansal M.A., Cummings K.M., Hyland A., and Giovino G.A. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them?. Nicotine Tob Res 6 3S (2004) S303-S310